Synergistic interaction between sorafenib and gemcitabine in EGFRTKIsensitive and EGFRTKIresistant human lung cancer cell lines

By      

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 440-446

Spandidos Publications

Access to resources Recommend Favorite

Synergistic interaction between MEK inhibitor and gefitinib in EGFRTKIresistant human lung cancer cells

By            

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2652-2656

Spandidos Publications

Access to resources Recommend Favorite

1Oacetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A549 human nonsmall cell lung cancer cells

By      

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5568-5572

Spandidos Publications

Access to resources Recommend Favorite

Stimulatory effects of sorafenib on human nonsmall cell lung cancer cells in vitro by regulating MAPK/ERK activation

By                

Molecular Medicine Reports, Vol. 9, Iss. 1, 2014-01 ,pp. : 365-369

Spandidos Publications

Access to resources Recommend Favorite

Sequencedependent effect of gemcitabine and cisplatin on A549 nonsmallcell lung cancer cells

By Tang Yu   Wang Yan   Teng Xiuzhi  

Molecular Medicine Reports, Vol. 8, Iss. 1, 2013-07 ,pp. : 221-226

Spandidos Publications

Access to resources Recommend Favorite